3 active not recruiting, 1 unknown. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Unknown 1 |
| Phase 3 | 2 | Active not recruiting 2 |
Follow Anal Basaloid Carcinoma: new trials by email Literature Review of Anal Basaloid Carcinoma trials Research Report on Anal Basaloid Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients Carboplatin, Nivolumab, Paclitaxel - Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 205 | 2020-11-17 | 2026-10-26 |
| Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study Biopsy, Biospecimen Collection, Capecitabine - Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma | Phase 2 | Active not recruiting | ECOG-ACRIN Cancer Research Group | 252 | 2020-01-02 | 2026-10-19 |
| Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer Biopsy Procedure, Biospecimen Collection, Colonoscopy - Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 344 | 2018-07-05 | 2026-11-02 |
| Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal Cancer Capecitabine, Carboplatin, Cisplatin - Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma | Phase 2 | Unknown | ECOG-ACRIN Cancer Research Group | 91 | 2016-08-23 | 2023-06-22 |
Anal Canal Carcinoma (4) · Anus Neoplasms (4)
Anus Diseases (4) · Colorectal Neoplasms (4) · Digestive System Diseases (4) · Digestive System Neoplasms (4) · Gastrointestinal Diseases (4) · Gastrointestinal Neoplasms (4) · Intestinal Diseases (4) · Intestinal Neoplasms (4) · Neoplasms (4) · Neoplasms by Site (4) · Rectal Diseases (4) · Rectal Neoplasms (4)
Biopsy (2) · Capecitabine (2) · Carboplatin (2) · Fluorouracil (2) · Magnetic Resonance Spectroscopy (2) · Nivolumab (2) · Paclitaxel (2) · Specimen Handling (2) · Taxes (2) · dehydroftorafur (2) · 1,2-diaminocyclohexaneplatinum II citrate (1) · Cisplatin (1) · Colonoscopy (1) · Fluorodeoxyglucose F18 (1) · Mitomycin (1)
ECOG-ACRIN Cancer Research Group (2) · National Cancer Institute (NCI) (2)
United States (4) · Canada (1)
Cathy Eng (2) · Jennifer A Dorth (1) · Lakshmi Rajdev (1)
U10CA180820 (4)